Loading…

Cefazolin pharmacokinetics in premature infants

Objective Pharmacokinetic (PK) data to guide cefazolin dosing in premature infants are virtually non-existent. Therefore, we aimed to characterize cefazolin PK in infants aged ≤32 weeks of gestation at birth. Study Design We conducted a prospective, open-label PK and safety study of cefazolin in inf...

Full description

Saved in:
Bibliographic Details
Published in:Journal of perinatology 2019-09, Vol.39 (9), p.1213-1218
Main Authors: Balevic, Stephen J., Smith, P. Brian, Testoni, Daniela, Wu, Huali, Brouwer, Kim L. R., Zimmerman, Kanecia O., Rivera-Chaparro, Nazario D., Benjamin, Daniel K., Cohen-Wolkowiez, Michael
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective Pharmacokinetic (PK) data to guide cefazolin dosing in premature infants are virtually non-existent. Therefore, we aimed to characterize cefazolin PK in infants aged ≤32 weeks of gestation at birth. Study Design We conducted a prospective, open-label PK and safety study of cefazolin in infants ≤32 weeks gestation from a University Medical Center. We administered intravenous cefazolin and collected both timed and scavenged blood samples. We analyzed data using non-linear mixed effect modeling and simulated several dosage regimens to achieve target concentrations against methicillin-susceptible Staphylococcus aureus . Results We analyzed 40 samples from nine infants and observed that premature infants had lower clearance and greater volume of distribution for cefazolin compared to older children. The median (range) individual Bayesian estimates were 0.03 L/h/kg (0.01–0.08) for clearance and 0.39 L/kg (0.31–0.52) for volume. Conclusion Simulations suggested reduced cefazolin dosing based on postmenstrual age achieve target concentrations and potentially reduce unnecessary exposure.
ISSN:0743-8346
1476-5543
1476-5543
DOI:10.1038/s41372-019-0368-z